Artificial intelligent patient-controlled intravenous analgesia improves the outcomes of older patients with laparoscopic radical resection for colorectal cancer

Eur Geriatr Med. 2023 Dec;14(6):1403-1410. doi: 10.1007/s41999-023-00873-z. Epub 2023 Oct 17.

Abstract

Methods: Patients undergoing elective laparoscopic radical resection of colorectal cancer from July 2019 to May 2021 were selected. The patients were assigned to Ai-PCIA group and control group. Ai-PCIA group received postoperative analgesia management and effect evaluation through intelligent wireless analgesia system + postoperative follow-up twice a day, while control group received analgesia management and effect evaluation through ward physician feedback + postoperative follow-up twice a day. The pain numerical score (NRS), Richards-Campbell Sleep Scale (RCSQ), and adverse outcomes were collected and compared.

Results: A total of 60 patients (20 females and 40 males with average (78.26 ± 6.42) years old) were included. The NRS scores at rest and during activity of the Ai-PCA group at 8, 12, and 24 h after the operation were significantly lower than that of the control group (all P < 0.05). The RCSQ score of Ai-PCA group was significantly higher than that of control group on the 1st and 2nd days after operation (all P < 0.05). There were no significant differences in the incidence of dizziness and nausea, vomiting, and myocardial ischemia (all P > 0.05).

Conclusions: Ai-PCIA can improve the analgesic effect and sleep quality of older patients after laparoscopic radical resection, which may be promoted in clinical analgesia practice.

Keywords: Care; Colorectal cancer; Patient-controlled analgesia; Surgery.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Analgesia, Patient-Controlled*
  • Artificial Intelligence
  • Colorectal Neoplasms* / surgery
  • Female
  • Humans
  • Laparoscopy*
  • Male
  • Pain Management
  • Pain, Postoperative* / drug therapy
  • Pain, Postoperative* / prevention & control